| First Author | Sunaga H | Year | 2013 |
| Journal | Nat Commun | Volume | 4 |
| Pages | 2563 | PubMed ID | 24113622 |
| Mgi Jnum | J:221217 | Mgi Id | MGI:5638503 |
| Doi | 10.1038/ncomms3563 | Citation | Sunaga H, et al. (2013) Deranged fatty acid composition causes pulmonary fibrosis in Elovl6-deficient mice. Nat Commun 4:2563 |
| abstractText | Despite the established role of alveolar type II epithelial cells for the maintenance of pulmonary function, little is known about the deregulation of lipid composition in the pathogenesis of pulmonary fibrosis. The elongation of long-chain fatty acids family member 6 (Elovl6) is a rate-limiting enzyme catalysing the elongation of saturated and monounsaturated fatty acids. Here we show that Elovl6 expression is significantly downregulated after an intratracheal instillation of bleomycin (BLM) and in human lung with idiopathic pulmonary fibrosis. Elovl6-deficient (Elovl6(-)/(-)) mice treated with BLM exhibit severe fibroproliferative response and derangement of fatty acid profile compared with wild-type mice. Furthermore, Elovl6 knockdown induces a change in fatty acid composition similar to that in Elovl6(-)/(-) mice, resulting in induction of apoptosis, TGF-beta1 expression and reactive oxygen species generation. Our findings demonstrate a previously unappreciated role for Elovl6 in the regulation of lung homeostasis, and in pathogenesis and exacerbation of BLM-induced pulmonary fibrosis. |
